{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-09T12:21:53.352079+00:00",
  "news": [
    {
      "title": "NRG Energy, Amgen, Arista Networks: Trending Tickers - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObnVOUTZRM3QybXNYanVMSlVJdThXM195dVpKeWFFSHl0RHhqaG9SYlZYRVFaZFNFaEdteWlDVlUxRG9pX05QMU40VW1LMWNvenYtRUhaRFlSalRlN3haWWpEb2F2TDM5MmVuX19wVUlGY0Z5ZWF5Q0pyV0M0Vi04Mkd1NFdhUQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObnVOUTZRM3QybXNYanVMSlVJdThXM195dVpKeWFFSHl0RHhqaG9SYlZYRVFaZFNFaEdteWlDVlUxRG9pX05QMU40VW1LMWNvenYtRUhaRFlSalRlN3haWWpEb2F2TDM5MmVuX19wVUlGY0Z5ZWF5Q0pyV0M0Vi04Mkd1NFdhUQ?oc=5\" target=\"_blank\">NRG Energy, Amgen, Arista Networks: Trending Tickers</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-06T20:01:48+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen CEO says compounding is ‘less a direct issue’ for obesity drug MariTide - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNVEw3aHdyMXhkMFh6al8walNHZS1WbEJVTmgtZy1CWEF3U0FFNzUtcTZuY3JtZ2FHVDFCSmxmendnSzNTbXNON2ZsOW15dUk0RFZVVU5nV2dxbEhCWE5oRGE3M0VDMnRnMFl5YlFjZ3VCZmhPQ2FfNUdKMXdWUkx6ZkRjRDJCd0wyQWUyN3hCaE5NdGNuZVZGM0dIX3RadDdB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxNVEw3aHdyMXhkMFh6al8walNHZS1WbEJVTmgtZy1CWEF3U0FFNzUtcTZuY3JtZ2FHVDFCSmxmendnSzNTbXNON2ZsOW15dUk0RFZVVU5nV2dxbEhCWE5oRGE3M0VDMnRnMFl5YlFjZ3VCZmhPQ2FfNUdKMXdWUkx6ZkRjRDJCd0wyQWUyN3hCaE5NdGNuZVZGM0dIX3RadDdB?oc=5\" target=\"_blank\">Amgen CEO says compounding is ‘less a direct issue’ for obesity drug MariTide</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-08-06T15:23:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "Why I Still Don't Think Amgen Is A Buy (NASDAQ:AMGN) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPTEN4RXFYWVVWdGlKSWNSb3RSRjRuWlY1LUxWd3Yxd1RyYXZEakRTRWNIQ1M3RTVTRG1rVUtGaGJDbnVCejZXQnFGb21veVQwRGMySUU3WG43eE1YYk5RREwzNG5zX2Q3R2NPM1YtbS1iekYzWUs3OWNVOU1qdlhYczE1LXE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxPTEN4RXFYWVVWdGlKSWNSb3RSRjRuWlY1LUxWd3Yxd1RyYXZEakRTRWNIQ1M3RTVTRG1rVUtGaGJDbnVCejZXQnFGb21veVQwRGMySUU3WG43eE1YYk5RREwzNG5zX2Q3R2NPM1YtbS1iekYzWUs3OWNVOU1qdlhYczE1LXE?oc=5\" target=\"_blank\">Why I Still Don't Think Amgen Is A Buy (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-06T14:56:36+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Amgen’s Promising Study on Romosozumab for Osteogenesis Imperfecta - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOTW9jYV9DaTloTUpNai03My1aSkV0YXczOWJWY0NzRFdiSDZHLTJ1S3pHNk5WWm9xcXBXTE9oUnFoM2VESzI3UUdsM2tqMDBsZkVtNWdrZVoxSzJMdjRXekI5dktsZ1NYYlo0XzFBbXlRWmVTLTZXb1JaeFE5SGdvT2hQRV94a1ItWHFOaXAtZHoza19yQWRBZnk1eFlQdFVOdFdoZWMtZlBDcDdvYWw4d0dWMVZnT01t?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOTW9jYV9DaTloTUpNai03My1aSkV0YXczOWJWY0NzRFdiSDZHLTJ1S3pHNk5WWm9xcXBXTE9oUnFoM2VESzI3UUdsM2tqMDBsZkVtNWdrZVoxSzJMdjRXekI5dktsZ1NYYlo0XzFBbXlRWmVTLTZXb1JaeFE5SGdvT2hQRV94a1ItWHFOaXAtZHoza19yQWRBZnk1eFlQdFVOdFdoZWMtZlBDcDdvYWw4d0dWMVZnT01t?oc=5\" target=\"_blank\">Amgen’s Promising Study on Romosozumab for Osteogenesis Imperfecta</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-08T16:16:58+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Stocks to Watch Afterhours: AMD, Amgen, Snap - The Wall Street Journal",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5wNBVV95cUxPTWZYbHdxMVJtazN1S1hCZkxyYWN2Q0k4NXRaZEQxZ0d2YkhYNnBBYzNrbFpjaUwxSWNETVFrbG0tbG1Fal90anhETFpMTFZqWjdEWm9OdWRsWVJpLUF0d0JUVkpOVGxvUjRRZmxzdGUzUS0zbXB5Si1FbHBNeGlWbTR6Y1ZlcldyNzZpMXFucHpZTjFXdndJM0R2ckM2eUNjN0JGUGpyeVk5QzNwS2NfRlVyWGp1Z1RkM2RPN2lxb080QkY3cUFfbHgxbGNkbkVCa2dKOFZTT1Ywb1lYVXk4TU1XWjhzNzhXWXNhREE5Ml9iLWZMNjFkNjVTQUdwNF9McUhWeHYzUFU3MXU3YnVqeGNYVGxsS0ZhcThlLVdRcjBrblhXRU4xS3U4TEJSYmJQeE1EakJUMDJtd0xHV3dWdVY2ZWxYdFpMVXBCYkZsZzN4MTBYeTVnQ0dmZms4emF2Qk13TG9EVWhwTEVIbm9fcGRmU0FNX1IxZGJDM1lITl9OTjU1ZWRhalZQUmlPVk4xOWlrS0R1bmpQNWI3SWs5MWhNbXdqcERJVWxFc01oMDJOaEZKYS1vV2x2a21VMVJ1b3NQcWg4UUZYSVNNa1RIMF9TNTdBRkg4T05oZmhMZ2w2WG9CWWZB?oc=5\" target=\"_blank\">Stocks to Watch Afterhours: AMD, Amgen, Snap</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal</font>",
      "published": "2025-08-06T01:52:00+00:00",
      "source": "The Wall Street Journal"
    },
    {
      "title": "Amgen’s (NASDAQ:AMGN) Q2: Beats On Revenue - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMifEFVX3lxTE55Zk0xVTBnZ3hJTFpRTk9oLUc2OUJITWNOZUI2MXlOVWtBWmNLdm04YVlKUEV2RWl5RTdzd2lmNHlmbm1BeFpwQlBTeFJNbUtpNnVRY29iME9xN3BQX3RtWl85X1VFeEZ3VGRBQkVfVDZTSWJwb3EtZEFyNFc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifEFVX3lxTE55Zk0xVTBnZ3hJTFpRTk9oLUc2OUJITWNOZUI2MXlOVWtBWmNLdm04YVlKUEV2RWl5RTdzd2lmNHlmbm1BeFpwQlBTeFJNbUtpNnVRY29iME9xN3BQX3RtWl85X1VFeEZ3VGRBQkVfVDZTSWJwb3EtZEFyNFc?oc=5\" target=\"_blank\">Amgen’s (NASDAQ:AMGN) Q2: Beats On Revenue</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-05T23:31:17+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen's Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNcDN2R3g5SlJCTWgwczFyRVNGbGpYcVlpNFBldmk4dFhOdDZMNzhiOUswNWI2ZDYxb2pxR2k3UTZiYUE3MFVHY2lhUEI0SWtaLWw2bmw1NC1hZWFpQ09TVkVoSHhFVHp5cklkY2dGVUFLV1ZsX2o5VWtNOXZlaDI5Wg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxNcDN2R3g5SlJCTWgwczFyRVNGbGpYcVlpNFBldmk4dFhOdDZMNzhiOUswNWI2ZDYxb2pxR2k3UTZiYUE3MFVHY2lhUEI0SWtaLWw2bmw1NC1hZWFpQ09TVkVoSHhFVHp5cklkY2dGVUFLV1ZsX2o5VWtNOXZlaDI5Wg?oc=5\" target=\"_blank\">Amgen's Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-06T13:51:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen Inc (AMGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Robust Pipeline ... - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMid0FVX3lxTE0tbm1HQWhacnZ4ZEJDWWdNUEF1SU8yTlVMNHp0VDdfT3RkUEp4OVBBLVJmX2lFcENqOVpEclJfYUlmQmlGWl9RN3ZFQ0o3aWN0YTJtSFI4cHhLd3dJNVRwZHNGVWsxYVBWNWRmNFlVWERYc0ZScnY4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMid0FVX3lxTE0tbm1HQWhacnZ4ZEJDWWdNUEF1SU8yTlVMNHp0VDdfT3RkUEp4OVBBLVJmX2lFcENqOVpEclJfYUlmQmlGWl9RN3ZFQ0o3aWN0YTJtSFI4cHhLd3dJNVRwZHNGVWsxYVBWNWRmNFlVWERYc0ZScnY4?oc=5\" target=\"_blank\">Amgen Inc (AMGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Robust Pipeline ...</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-06T07:26:26+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "product_launches": [
    {
      "title": "Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva - koreabiomed.com",
      "link": "https://news.google.com/rss/articles/CBMibkFVX3lxTE51eEtJYkhkRHFlaDJiREhrQ3FTNFpINXVRT2xkNUo1dFROdWJLUF9fcm9EWVNWeW44S2JmR2FwQWpERUxRODRaTkZWRmpmQmFjWkQ5b0NaVm5DY005ZGlhTzQ4T2Z3ejJkT202am1R0gFyQVVfeXFMTWR6QWpUU2tQdnNiYmF2clROVVFIU2NFQzdnV3JOZUF0cHVaYVVmYTk0a01CSjA5N3ZMcnpZSllXWHhtWXZocnJySlgtMjhrbS1Yd1pIdEdOSzVVczllV0tFRHZRRjJ0dnJvbjZKOEdGandn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMibkFVX3lxTE51eEtJYkhkRHFlaDJiREhrQ3FTNFpINXVRT2xkNUo1dFROdWJLUF9fcm9EWVNWeW44S2JmR2FwQWpERUxRODRaTkZWRmpmQmFjWkQ5b0NaVm5DY005ZGlhTzQ4T2Z3ejJkT202am1R0gFyQVVfeXFMTWR6QWpUU2tQdnNiYmF2clROVVFIU2NFQzdnV3JOZUF0cHVaYVVmYTk0a01CSjA5N3ZMcnpZSllXWHhtWXZocnJySlgtMjhrbS1Yd1pIdEdOSzVVczllV0tFRHZRRjJ0dnJvbjZKOEdGandn?oc=5\" target=\"_blank\">Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">koreabiomed.com</font>",
      "published": "2025-08-04T01:50:03+00:00",
      "source": "koreabiomed.com"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-08",
      "close": 288.2300109863281
    },
    "history": [
      {
        "date": "2025-07-31",
        "close": 295.1000061035156
      },
      {
        "date": "2025-08-01",
        "close": 296.8800048828125
      },
      {
        "date": "2025-08-04",
        "close": 301.94000244140625
      },
      {
        "date": "2025-08-05",
        "close": 300.0799865722656
      },
      {
        "date": "2025-08-06",
        "close": 284.6700134277344
      },
      {
        "date": "2025-08-07",
        "close": 284.70001220703125
      },
      {
        "date": "2025-08-08",
        "close": 288.2300109863281
      }
    ],
    "name": "Amgen Inc."
  }
}